AN Venture Partners
Venture capitalActively deployingTokyo · Pre-Seed–Growth · 22 people tracked
Also known as ANV MANAGEMENT, LLC
Find your way into AN Venture Partners
3,714 people in our graph share verified history with the AN Venture Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
AN Venture Partners positions itself at the intersection of science, capital, and innovation, aiming to advance scientific progress on a global scale. The firm invests in startups it believes will shape the future, drawing on a highly experienced core team and a worldwide network of experts. Its emphasis on scientific and deep-technology ventures suggests a focus on research-driven companies, though the page does not detail specific stages, check sizes, or sectors.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curated
Founder mafia
2 people who came through AN Venture Partners went on to found or lead other companies.
What they invest in
from 7 of 8 portfolio companiesBiotech ×7Healthtech ×4Deep Tech ×2Medical Devices ×2Digital Health ×1Longevity ×1
HQs:United States×3Japan×1
Investments · 8 tracked
founders shown can be your intro pathPAhR Therapeutics is a clinical-stage biotech company developing novel mechanisms to treat pulmonary arterial hypertension (PAH).
BiotechHealthtech
Co-investorsRA CapitalUTEC
Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria.
BiotechDeep TechLongevityPalo Alto, US
Amy Wang(PhD)inKenneth Horne(Executive Officer, Director)inDylan Morris(Director)inCristina Ghenoiu(Director)in
BoardTaro Inaba(Director)in
Co-investorsRemiges Ventures, Inc.Insight PartnersRA CapitalRDiscovery
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)
Co-investorsARCH Venture PartnersSofinnova VenturesCasdin CapitalFidelity InvestmentsInvusRock Springs Capital
Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid.
BiotechHealthtechMedical DevicesSan Diego, US
James Mackay(President & Chief Executive Officer)inNihar Bhakta(Chief Medical Officer)inAshwin Ram(Chief Operating Officer)inDeAnne Reid(Chief Administrative Officer)in
Co-investorsCatalys PacificNovo HoldingsFrazier Life SciencesLightstone VenturesLongwood Fund
Imbria Pharmaceuticals develops novel cardiovascular disease treatments that target cardiac energy metabolism, with a lead drug candidate, ninerafaxstat, in clinical trials for non-obstructive hypertrophic cardiomyopathy.
BiotechDigital Health
Alvin Shih(CEO)inAlbert M. Kim(Chief Medical Officer)in
Co-investorsCatalio Capital Management, LPRA CapitalSanofi VenturesSV Health InvestorsCatalio Capital Management
Tortugas Neuro is a neuroscience drug development company focused on the neurology and neuropsychiatry space, working to advance clinical-stage therapies for brain health.
BiotechHealthtech
Co-investorsCure VenturesThe Column Group
Typewriter Therapeutics develops mRNA-based gene therapies using a platform for targeted insertion of therapeutic genes, building on transposon research from the University of Tokyo.
BiotechDeep TechHealthtechTokyo, JP
Jun Zhou, PhD(Founder & Vice President, Discovery and Global Operations)Haruhiko Fujiwara, PhD(Founder & Advisor · Professor Emeritus, University of Tokyo)Tom Eickbush, PhD(Co-founder & Advisor · Professor Emeritus, University of Rochester)Kei Endo, PhD(Co-founder & Advisor · Associate Professor, University of Tokyo)Jim Collins, PhD(Co-founder & Advisor - Professor, MIT)Matthew Stanton, PhD(Chief Executive Officer)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Tortugas Neuroscience
Portfolio news
latest coverage across their companiesCity Therapeutics · finsmes.com · Jun 9, 2026
Imbria · finsmes.com · Nov 19, 2025
Frequently asked questions
- How many investments has AN Venture Partners made?
- AN Venture Partners has 8 tracked investments.
- What stage does AN Venture Partners invest at?
- AN Venture Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does AN Venture Partners focus on?
- AN Venture Partners focuses on Biotech, Deep Tech.
- Where is AN Venture Partners located?
- AN Venture Partners is headquartered in Tokyo, JP.
- Does AN Venture Partners lead rounds?
- AN Venture Partners typically participates in rounds rather than leading them.
- Who does AN Venture Partners co-invest with?
- AN Venture Partners most often shares deals with Cure Ventures, ARCH Venture Partners, Lightstone Ventures, among 12 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Rodrigo Sepúlveda Schulz is a senior technology executive and investor who leads the international expansion of Stratio.ai, an AI-powered decision intelligence platform for enterprises and governments, while serving as president of his family office, Sepulveda Capital. He has participated in over 100 financing transactions with a track record including three billion-dollar exits and extensive advisory work across technology ventures.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Innventure is a venture capital fund specializing in AgTech, backed by a community of agricultural producers, entrepreneurs and investors who co-invest in startups transforming the agrifood industry.